莎普爱思品牌怎么样 申请店铺

我要投票 莎普爱思在滴眼液行业中的票数:278 更新时间:2025-04-27
莎普爱思是哪个国家的品牌?「莎普爱思」是 浙江莎普爱思药业股份有限公司 旗下著名品牌。该品牌发源于浙江,由创始人陈德康在2000-07-17期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力莎普爱思品牌出海!通过在本页面挂载莎普爱思品牌的产品链接和联系方式,可以提高莎普爱思产品曝光!跨境电商爆单神器,目前只要100元/年哦~

莎普爱思怎么样

公司自1978年建厂以来,经历了从“国营浙江平湖制药厂”转制成“浙江平湖制药厂(股份合作)”到“浙江平湖莎普爱思制药有限公司”,再到“浙江莎普爱思制药有限公司”,最终于2008年12月15日更名为“浙江莎普爱思药业股份有限公司”,目前注册资金为4900万元人民币。

公司作为一家专业从事药品研发、生产、经营的综合性制药企业,先后被列为“国家高新技术企业”、“浙江省百家最具投资价值企业”、“浙江省千家成长之星企业”、“浙江省级企业技术中心”、“省级高新技术研究开发中心”、“浙江省标准创新型企业”、“嘉兴市重点企业技术创新团队”、“院士专家工作站”等多项荣誉称号。

目前公司拥有大容量注射剂(玻璃瓶、塑料瓶和多层共挤膜袋)、口服溶液剂、滴眼剂、片剂(含头孢菌素类)、硬胶囊剂(含头孢菌素类)、栓剂、颗粒剂(含头孢菌素类)、干混悬剂(含头孢菌素类)、冲洗剂共10个剂型,近百种规格的产品批准文号。抗白内障新药“莎普爱思”滴眼液和抗青光眼新药“达靓”滴眼液被列入“国家火炬计划项目”。“莎普爱思”滴眼液还荣获国家重点科技攻关项目、国家重点新产品、浙江省名牌产品等多个称号,是国内第一个国家二类眼科专科新药。

几十年来,公司凭着优质的产品,良好的信誉,在市场竞争日益激烈的情况下,赢得了市场,产品销往全国各地,取得了良好的经济效益。近年来公司的产品销量与销售额都呈现出逐年增涨的态势,是平湖市重点扶持的股改上市企业。

在竞争激烈的医药市场中,我公司始终坚持科技兴业、加强管理、保证质量,不断推出各种自主研发的新产品。公司秉承“科技创新、求是进取、优质高效、和谐健康”的企业精神,不断寻求创新与突破,逐步使公司成为现代化、高科技制药企业。

莎普爱思的未来将坚持以市场为导向,发展为主题,科技创新为核心。以保护和增进人民健康、提高人民福祉为目标。我们确信莎普爱思的无限“关爱”会遍及中国,走向世界。

Since its establishment in 1978, the company has gone through the transformation from "state-owned Zhejiang Pinghu pharmaceutical factory" to "Zhejiang Pinghu pharmaceutical factory (joint stock cooperation)" to "Zhejiang Pinghu sapais Pharmaceutical Co., Ltd." and then to "Zhejiang sapais Pharmaceutical Co., Ltd." and finally changed its name to "Zhejiang sapais pharmaceutical Co., Ltd." on December 15, 2008, with the current registered capital of 49 million yuan RMB. As a comprehensive pharmaceutical enterprise specializing in drug R & D, production and operation, the company has been listed as "national high-tech enterprise", "one hundred enterprises with the most investment value in Zhejiang Province", "one thousand growth star enterprises in Zhejiang Province", "Zhejiang provincial enterprise technology center", "provincial high-tech research and development center", "Zhejiang standard innovation enterprise" "Jiaxing key enterprise technology innovation team", "academician expert workstation" and other honorary titles. At present, the company has 10 dosage forms of large capacity injection (glass bottles, plastic bottles and multi-layer coextrusion film bags), oral solution, eye drops, tablets (including cephalosporins), hard capsules (including cephalosporins), suppositories, granules (including cephalosporins), dry suspension (including cephalosporins), washing agents, and approval numbers of nearly 100 specifications of products. The new anti cataract drug "sapais" eye drops and the new anti glaucoma drug "Daliang" eye drops are listed in the "National Torch Program project". "Saps eye drops" also won the titles of national key scientific and technological research projects, national key new products, Zhejiang famous brand products, etc., and is the first national class II ophthalmic specialty new drug in China. In the past few decades, with its high quality products and good reputation, the company has won the market and sold its products to all parts of the country under the increasingly fierce market competition, and achieved good economic benefits. In recent years, the sales volume and sales volume of the company have been increasing year by year. It is a listed company supported by Pinghu City. In the highly competitive pharmaceutical market, our company always adheres to the development of science and technology, strengthening management, ensuring quality, and constantly launches various new products independently researched and developed. The company adheres to the enterprise spirit of "scientific and technological innovation, truth-seeking and enterprising, high-quality and efficient, harmonious and healthy", constantly seeks innovation and breakthrough, and gradually makes the company become a modern, high-tech pharmaceutical enterprise. In the future, SAPS will adhere to the market-oriented, development oriented theme and technological innovation as the core. With the goal of protecting and promoting people's health and improving people's well-being. We are sure that the infinite "love" of sapeus will spread all over China and go to the world.

本文链接: https://brand.waitui.com/a5a71ec58.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

全球首个商用智算昇腾超节点正式发布

4月26日,中国电信粤港澳大湾区智算昇腾超节点发布会,在韶关数据中心集群——中国电信粤港澳大湾区智算中心举行,全球首个商用智算昇腾超节点正式发布。(界面)

2小时前

科大讯飞发布新一代智慧课堂解决方案

4月25日,在AI赋能基础教育教学变革学术交流大会暨第五届教育装备学术大会上,科大讯飞副总裁周佳峰正式发布新一代智慧课堂解决方案,包括更新后的“星火教师助手”“AI黑板”和“AI学伴”。其中上线后的 AI 学伴,覆盖课前预习、课中学习、课后复习、精准备考、家校共育等全场景。

2小时前

全球首款三涵道穿戴式单人飞行器在杭州成功首飞

国内首创基于三涵道构型的穿戴式单人飞行器在杭州成功首飞。该飞行器由杭州智元研究院研发,续航里程≥8km,最大飞行高度≥1km,续航时间≥20min,最大速度≥60km/h。杭州智元研究院高级工程师田聪玲介绍,其采用涵道动力与舵面融合控制,有高效、可靠的特点。在人机交互方面,该飞行器可配合AR头盔和摇杆操作实现智能交互,在自动驾驶状态下能解放双手,实现高空作业。从应用看,其可应用于应急救援、飞行体验、低空经济空中作业等场景。(财联社)

2小时前

美国电商平台集体提价

近期特朗普关税政策导致全球贸易紧张局势加剧,商家运营成本上升。据美国媒体4月25日报道,美国亚马逊等电商平台上不少商家已经开始提高商品的售价。根据一家价格分析机构提供的数据,自4月9日以来,美国亚马逊网站上近1000种商品的价格出现明显上涨,涵盖服装、家居用品、电子产品和玩具等多个类别,平均涨价幅度接近30%。包括Temu、希音等多个跨境电商平台均已发布公告称,由于“近期全球贸易规则及关税变动”导致运营成本上升,将从4月25日开始实施价格调整。社交媒体上也有大量美国网友感叹道,一夜之间购物车里的东西都变贵了。 (央视财经)

2小时前

新版国家卫生监督抽查计划发布 首次明确打击网络“医托”

国家疾控局等3部门近日联合发布医疗卫生领域《2025年国家随机监督抽查计划》。相较于2024年计划,2025年计划在监管范围等方面作出调整,新增互联网诊疗、精神卫生等监管领域,并首次明确打击网络“医托”等新型违法行为,进一步强化公共卫生和医疗秩序治理。(财联社)

2小时前

本页详细列出关于莎普爱思的品牌信息,含品牌所属公司介绍,莎普爱思所处行业的品牌地位及优势。
咨询